Metastatic behavior of upper tract urothelial carcinoma after radical nephroureterectomy: Association with primary tumor location

Annals of Surgical Oncology

Volumn 21, Issue 3, 2014, Pages 1038-1045

  Tanaka, Nobuyuki ^a,h   Kikuchi, Eiji ^a   Kanao, Kent ^a   Matsumoto, Kazuhiro ^a,b   Kobayashi, Hiroaki ^a,g   Ide, Hiroki ^a,c   Miyazaki, Yasumasa ^a,i   Obata, Jun ^a,d   Hoshino, Katsura ^a,f   Shirotake, Suguru ^a,j   Akita, Hirotaka ^a   Kosaka, Takeo ^a,k   Miyajima, Akira ^a   Momma, Tetsuo ^e   Nakagawa, Ken ^a   Hasegawa, Shintaro ^d   Nakajima, Yosuke ^f   Jinzaki, Masahiro ^a   Oya, Mototsugu ^a  

^a KEIO UNIVERSITY   (Japan)

^b SAISEIKAI CENTRAL HOSPITAL   (Japan)

^c Saitama City Hospital   (Japan)

^d National Hospital Organization Tochigi Medical Center   (Japan)

^e SAITAMA NATIONAL HOSPITAL   (Japan)

^f SAISEIKAI YOKOHAMASHI TOBU HOSPITAL   (Japan)

^g Federation of National Public Service Personnel Mutual Aid Associations   (Japan)

^h Musashino Hospital   (Japan)

ⁱ Ogikubo Hospital   (Japan)

^j Inagi City Hospital   (Japan)

^k Irumagawa Hospital   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BONE; CANCER ADJUVANT THERAPY; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY PELVIS; KIDNEY PELVIS TUMOR; LIVER; LUNG; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; NEPHROURETERECTOMY; OUTCOME ASSESSMENT; PRIMARY TUMOR; RADICAL NEPHROURETERECTOMY; RETROSPECTIVE STUDY; TRANSITIONAL CELL CARCINOMA; URETER; URETER TUMOR;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS; NEPHRECTOMY; PELVIC NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; URETERAL NEOPLASMS; UROLOGIC SURGICAL PROCEDURES;

EID: 84896735500     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-013-3349-z     Document Type: Article

References (28)

1. Roupret M, Zigeuner R, Palou J, et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol. 2011;59:584-94.
2. Margulis V, Shariat SF, Matin SF, et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer. 2009;115:1224-33.
3. Kikuchi E, Margulis V, Karakiewicz PI, et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol. 2009;27:612-8.
4. Zigeuner R, Shariat SF, Margulis V, et al. Tumour necrosis is an indicator of aggressive biology in patients with urothelial carcinoma of the upper urinary tract. Eur Urol. 2010;57:575-81.
5. Yates DR, Hupertan V, Colin P, et al. Cancer-specific survival after radical nephroureterectomy for upper urinary tract urothelial carcinoma: proposal and multi-institutional validation of a post-operative nomogram. Br J Cancer. 2012;106:1083-8.
6. Lughezzani G, Burger M, Margulis V, et al. Prognostic factors in upper urinary tract urothelial carcinomas: a comprehensive review of the current literature. Eur Urol. 2012;62:100-14.
7. Shariat SF, Zigeuner R, Rink M, et al. Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. Eur Urol. 2012;62:224-31.
8. Kondo T, Nakazawa H, Ito F, et al. Impact of the extent of regional lymphadenectomy on the survival of patients with urothelial carcinoma of the upper urinary tract. J Urol. 2007;178:1212-7.
9. Kondo T, Nakazawa H, Ito F, et al. Primary site and incidence of lymph node metastases in urothelial carcinoma of upper urinary tract. Urology. 2007;69:265-9.
10. Rink M, Fajkovic H, Cha EK, et al. Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma. Eur Urol. 2012;61:854-5.
11. Abe T, Shinohara N, Harabayashi T, et al. Impact of multimodal treatment on survival in patients with metastatic urothelial cancer. Eur Urol. 2007;52:1106-13.
12. Lehmann J, Suttmann H, Albers P, et al. Surgery for metastatic urothelial carcinoma with curative intent: the German experience (AUO AB 30/05). Eur Urol. 2009;55:1293-9.
13. Chromecki TF, Cha EK, Fajkovic H, et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol. 2012;61:245-53.
14. Cha EK, Shariat SF, Kormaksson M, et al. Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. Eur Urol. 2012;61:818-25.
15. Novara G, Matsumoto K, Kassouf W, et al. Prognostic role of lymphovascular invasion in patients with urothelial carcinoma of the upper urinary tract: an international validation study. Eur Urol. 2010;57:1064-71.
16. Stein JP, Lieskovsky G, Cote R, et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J Clin Oncol. 2001;19:666-75.
17. Madersbacher S, Hochreiter W, Burkhard F, et al. Radical cystectomy for bladder cancer today - a homogeneous series without neoadjuvant therapy. J Clin Oncol. 2003;21:690-6.
18. Yossepowitch O, Dalbagni G, Golijanin D, et al. Orthotopic urinary diversion after cystectomy for bladder cancer: implications for cancer control and patterns of disease recurrence. J Urol. 2003;169:177-81.
19. Hautmann RE, Gschwend JE, de Petriconi RC, et al. Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era. J Urol. 2006;176:486-92.
20. Bochner BH, Montie JE, Lee CT. Follow-up strategies and management of recurrence in urologic oncology bladder cancer: invasive bladder cancer. Urol Clin North Am. 2003;30:777-89.
21. Umbreit EC, Crispen PL, Shimko MS, et al. Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma. Cancer. 2010;116:3399-407.
22. Shinagare AB, Ramaiya NH, Jagannathan JP, et al. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor. AJR Am J Roentgenol. 2011;196:117-22.
23. Hall MC, Womack JS, Roehrborn CG, et al. Advanced transitional cell carcinoma of the upper urinary tract: patterns of failure, survival and impact of postoperative adjuvant radiotherapy. J Urol. 1998;160:703-6.
24. Brown GA, Busby JE, Wood CG, et al. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: time to change the treatment paradigm? BJU Int. 2006;98:1176-80.
25. Roscigno M, Shariat SF, Margulis V, et al. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol. 2009;181:2482-9.
26. Roscigno M, Cozzarini C, Bertini R, et al. Prognostic value of lymph node dissection in patients with muscle-invasive transitional cell carcinoma of the upper urinary tract. Eur Urol. 2008;53:794-802.
27. Roscigno M, Brausi M, Heidenreich A, et al. Lymphadenectomy at the time of nephroureterectomy for upper tract urothelial cancer. Eur Urol. 2011;60:776-83.
28. Herr HW, Faulkner JR, Grossman HB, et al. Surgical factors influence bladder cancer outcomes: a cooperative group report. J Clin Oncol. 2004;22:2781-9.